Distant metastases in papillary thyroid carcinoma: 100 Cases observed at one institution during 5 decades

S. F. Dinneen, M. J. Valimaki, E. J. Bergstralh, J. R. Goellner, C. A. Gorman, Ian D Hay

Research output: Contribution to journalArticle

222 Citations (Scopus)

Abstract

The present study was designed to define the factors that predict survival in patients with distant metastases (DM) from papillary thyroid carcinoma. We performed a retrospective review of the records of 100 consecutive patients (45 females and 55 males; age range, 8-91 yr) who developed DM after primary treatment at our institution from, 1940-1989. Median follow-up for the 20 survivors was 21 yr (range, 3-38). Cause-specific survival rates at 5, 10, and 15 yr were 40%, 27%, and 24%, respectively, and were not significantly different between the eras 1940-1954, 1955-1969, and 1970-1989 (P = 0.74). By univariate analysis, age at diagnosis of DM was the most important predictor of survival (P < 0.0001), with improved survival occurring in younger patients. Tumor-related factors associated with improved survival included complete resection of the primary tumor (P < 0.005), histological grade 1 (P = 0.006), diploid nuclear DNA (P = 0.03), and lung as first site of DM (P = 0.018). By univariate analysis, use of radioiodine therapy was associated with improved survival (vs. other forms of therapy, P < 0.001). However, by multivariate analysis only age, site of DM, and degree of extrathyroidal invasion of the primary tumor were identified as significant predictors of survival. None of the four treatment variables (external radiation, surgery, chemotherapy, or radioiodine) was a significant predictor of survival in the Cox model. Our retrospective data indicate that 1) outcome has changed little over 5 decades for patients with DM from papillary thyroid carcinoma; and 2) current forms of therapy do not appear to impact on survival.

Original languageEnglish (US)
Pages (from-to)2041-2045
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume80
Issue number7
StatePublished - 1995

Fingerprint

Tumors
Neoplasm Metastasis
Survival
Chemotherapy
Surgery
Radiation
DNA
Therapeutics
Neoplasms
Papillary Thyroid cancer
Diploidy
Proportional Hazards Models
Survivors
Multivariate Analysis
Survival Rate
Drug Therapy
Lung

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Dinneen, S. F., Valimaki, M. J., Bergstralh, E. J., Goellner, J. R., Gorman, C. A., & Hay, I. D. (1995). Distant metastases in papillary thyroid carcinoma: 100 Cases observed at one institution during 5 decades. Journal of Clinical Endocrinology and Metabolism, 80(7), 2041-2045.

Distant metastases in papillary thyroid carcinoma : 100 Cases observed at one institution during 5 decades. / Dinneen, S. F.; Valimaki, M. J.; Bergstralh, E. J.; Goellner, J. R.; Gorman, C. A.; Hay, Ian D.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 80, No. 7, 1995, p. 2041-2045.

Research output: Contribution to journalArticle

Dinneen, SF, Valimaki, MJ, Bergstralh, EJ, Goellner, JR, Gorman, CA & Hay, ID 1995, 'Distant metastases in papillary thyroid carcinoma: 100 Cases observed at one institution during 5 decades', Journal of Clinical Endocrinology and Metabolism, vol. 80, no. 7, pp. 2041-2045.
Dinneen, S. F. ; Valimaki, M. J. ; Bergstralh, E. J. ; Goellner, J. R. ; Gorman, C. A. ; Hay, Ian D. / Distant metastases in papillary thyroid carcinoma : 100 Cases observed at one institution during 5 decades. In: Journal of Clinical Endocrinology and Metabolism. 1995 ; Vol. 80, No. 7. pp. 2041-2045.
@article{c0c40901a7c24fb19c398aeb05cd0912,
title = "Distant metastases in papillary thyroid carcinoma: 100 Cases observed at one institution during 5 decades",
abstract = "The present study was designed to define the factors that predict survival in patients with distant metastases (DM) from papillary thyroid carcinoma. We performed a retrospective review of the records of 100 consecutive patients (45 females and 55 males; age range, 8-91 yr) who developed DM after primary treatment at our institution from, 1940-1989. Median follow-up for the 20 survivors was 21 yr (range, 3-38). Cause-specific survival rates at 5, 10, and 15 yr were 40{\%}, 27{\%}, and 24{\%}, respectively, and were not significantly different between the eras 1940-1954, 1955-1969, and 1970-1989 (P = 0.74). By univariate analysis, age at diagnosis of DM was the most important predictor of survival (P < 0.0001), with improved survival occurring in younger patients. Tumor-related factors associated with improved survival included complete resection of the primary tumor (P < 0.005), histological grade 1 (P = 0.006), diploid nuclear DNA (P = 0.03), and lung as first site of DM (P = 0.018). By univariate analysis, use of radioiodine therapy was associated with improved survival (vs. other forms of therapy, P < 0.001). However, by multivariate analysis only age, site of DM, and degree of extrathyroidal invasion of the primary tumor were identified as significant predictors of survival. None of the four treatment variables (external radiation, surgery, chemotherapy, or radioiodine) was a significant predictor of survival in the Cox model. Our retrospective data indicate that 1) outcome has changed little over 5 decades for patients with DM from papillary thyroid carcinoma; and 2) current forms of therapy do not appear to impact on survival.",
author = "Dinneen, {S. F.} and Valimaki, {M. J.} and Bergstralh, {E. J.} and Goellner, {J. R.} and Gorman, {C. A.} and Hay, {Ian D}",
year = "1995",
language = "English (US)",
volume = "80",
pages = "2041--2045",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "7",

}

TY - JOUR

T1 - Distant metastases in papillary thyroid carcinoma

T2 - 100 Cases observed at one institution during 5 decades

AU - Dinneen, S. F.

AU - Valimaki, M. J.

AU - Bergstralh, E. J.

AU - Goellner, J. R.

AU - Gorman, C. A.

AU - Hay, Ian D

PY - 1995

Y1 - 1995

N2 - The present study was designed to define the factors that predict survival in patients with distant metastases (DM) from papillary thyroid carcinoma. We performed a retrospective review of the records of 100 consecutive patients (45 females and 55 males; age range, 8-91 yr) who developed DM after primary treatment at our institution from, 1940-1989. Median follow-up for the 20 survivors was 21 yr (range, 3-38). Cause-specific survival rates at 5, 10, and 15 yr were 40%, 27%, and 24%, respectively, and were not significantly different between the eras 1940-1954, 1955-1969, and 1970-1989 (P = 0.74). By univariate analysis, age at diagnosis of DM was the most important predictor of survival (P < 0.0001), with improved survival occurring in younger patients. Tumor-related factors associated with improved survival included complete resection of the primary tumor (P < 0.005), histological grade 1 (P = 0.006), diploid nuclear DNA (P = 0.03), and lung as first site of DM (P = 0.018). By univariate analysis, use of radioiodine therapy was associated with improved survival (vs. other forms of therapy, P < 0.001). However, by multivariate analysis only age, site of DM, and degree of extrathyroidal invasion of the primary tumor were identified as significant predictors of survival. None of the four treatment variables (external radiation, surgery, chemotherapy, or radioiodine) was a significant predictor of survival in the Cox model. Our retrospective data indicate that 1) outcome has changed little over 5 decades for patients with DM from papillary thyroid carcinoma; and 2) current forms of therapy do not appear to impact on survival.

AB - The present study was designed to define the factors that predict survival in patients with distant metastases (DM) from papillary thyroid carcinoma. We performed a retrospective review of the records of 100 consecutive patients (45 females and 55 males; age range, 8-91 yr) who developed DM after primary treatment at our institution from, 1940-1989. Median follow-up for the 20 survivors was 21 yr (range, 3-38). Cause-specific survival rates at 5, 10, and 15 yr were 40%, 27%, and 24%, respectively, and were not significantly different between the eras 1940-1954, 1955-1969, and 1970-1989 (P = 0.74). By univariate analysis, age at diagnosis of DM was the most important predictor of survival (P < 0.0001), with improved survival occurring in younger patients. Tumor-related factors associated with improved survival included complete resection of the primary tumor (P < 0.005), histological grade 1 (P = 0.006), diploid nuclear DNA (P = 0.03), and lung as first site of DM (P = 0.018). By univariate analysis, use of radioiodine therapy was associated with improved survival (vs. other forms of therapy, P < 0.001). However, by multivariate analysis only age, site of DM, and degree of extrathyroidal invasion of the primary tumor were identified as significant predictors of survival. None of the four treatment variables (external radiation, surgery, chemotherapy, or radioiodine) was a significant predictor of survival in the Cox model. Our retrospective data indicate that 1) outcome has changed little over 5 decades for patients with DM from papillary thyroid carcinoma; and 2) current forms of therapy do not appear to impact on survival.

UR - http://www.scopus.com/inward/record.url?scp=0028997547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028997547&partnerID=8YFLogxK

M3 - Article

C2 - 7608252

AN - SCOPUS:0028997547

VL - 80

SP - 2041

EP - 2045

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 7

ER -